Лучшие подкасты про Hepatocellular (2024)

1
Spotlight on Liver MRI: Diagnosing and Managing Hepatocellular Carcinoma 33:45

11d ago33:45

33:45

In the face of the rising incidence of liver disease, how is your multidisciplinary team using imaging for surveillance and management of patients with hepatocellular carcinoma (HCC)? Credit available for this activity expires: 9/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001653?ecd=bdc_podcast_libs…

1
Momelotinib vs. Ruxolitinib: Comparing Efficacy in Myelofibrosis and Anemia Patients

5d ago

—

Host: Matt Birnholz, MD The SIMPLIFY-2 trial compared the efficacy of momelotinib to best available therapy, which was primarily continued ruxolitinib, in patients with myelofibrosis and anemia who were previously treated with a JAK inhibitor. According to the findings, momelotinib potentially offers better outcomes and a more comprehensive managem…

1
ESMO 2024 Congress Highlights in Gynecologic Cancer: New Data Informing Treatment of Ovarian, Endometrial, and Cervical Cancers 30:45

6d ago30:45

30:45

In this episode, listen to Ana Oaknin, MD, PhD and Alexandra Leary, MD, PhD, share their clinical insights and takeaways on key updates and new data presented for ovarian, endometrial, and cervical cancer at the ESMO 2024 annual congress including: Phase III PRIMA/ENGOT-OV26/GOG-3012 Final OS Results: Niraparib as First-Line Maintenance in Advanced…

1
Gastric intestinal metaplasia: reviewing current guidelines 20:06

6d ago20:06

20:06

Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Mario Dinis-Ribeiro from the Department of Gastroenterology at Porto Comprehensive Cancer Center & RISE—Health Research Network, Porto, Portugal, on the paper "The road to a world-unifie…

1
Updates on Renal Denervation From the 2024 European Society of Cardiology Guidelines on Hypertension 24:36

6d ago24:36

24:36

What’s changed in how we should manage resistant hypertension? Credit available for this activity expires: 9/30/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001663?ecd=bdc_podcast_libsyn_mscpedu

1
Hidden Unmet Needs in Schizophrenia: What Every Healthcare Professional Needs to Know 18:59

7d ago18:59

18:59

Lively Quickfire session on helping patients with cognitive and negative symptoms. Credit available for this activity expires: 9/30/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001571?ecd=bdc_podcast_libsyn_mscpedu

1
A Cancer Conversation: Optimizing the Care of Patients With CLL Through a Deeper Understanding of BTK Inhibitor Resistance 32:48

7d ago32:48

32:48

In this episode, listen to Matthew S. Davids, MD, MMSc, and Lindsey Roeker, MD, discuss BTK inhibitor resistance and how it shapes treatment choices for patients with CLL, including: Contemporary treatment paradigms for patients with CLL Safety and efficacy of current regimens Molecular testing, including when and how to test for BTK inhibitor res…

1
Modeling Guideline-Concordant Therapy Selection in the Adjuvant Setting for Endometrial Cancer 28:24

12d ago28:24

28:24

Do you know the best approaches to managing patients with endometrial cancer in the adjuvant setting? Credit available for this activity expires: 9/24/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001649?ecd=bdc_podcast_libsyn_mscpedu

1
Evolution of HER2-Targeted Therapy in Biliary Tract Cancer 24:04

17d ago24:04

24:04

Do you know which type of biliary tract cancer (BTC) has the highest rate of HER2 aberrations? Credit available for this activity expires: 9/20/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001632?ecd=bdc_podcast_libsyn_mscpedu

1
Spotlight on Liver MRI: Fatty Liver Disease 26:08

21d ago26:08

26:08

How does magnetic resonance imaging (MRI) play a role in identifying biomarkers for patients with steatotic liver disease? Credit available for this activity expires: 9/13/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001595?ecd=bdc_podcast_libsyn_mscpedu…

1
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases

21d ago

—

Guest: Betsy O'Donnell, MD Plasma cell disorders range from multiple myeloma to the monoclonal gammopathy of undetermined significance (MGUS), which is a benign condition that affects anywhere between 3 and 10 percent of the population starting at age 50. However, about 1 percent of people per year who have MGUS will progress to multiple myeloma. H…

1
Insights from ICARUS-Lung01: Efficacy and Safety of Dato-DXd for NSCLC

28d ago

—

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Joshua E. Reuss, MD The phase 2 ICARUS-Lung01 study evaluated not only the efficacy and safety of datopotomab deruxtecan (Dato-DXd) in patients with previously treated advanced non-small cell lung cancer (NSCLC), but also potential biomarkers associated with response and/or resistance. Here to discuss…

1
Available and Emerging Therapies for Progressive/Recurrent ROS1-Altered Advanced NSCLC 13:53

1M ago13:53

13:53

In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available and emerging clinical data for second-line and beyond treatments in patients with recurrent ROS1-altered advanced NSCLC including: Assessing ROS1-TKI resistance mutations with tumor and liquid biopsies in patients with ROS1-altered advan…

1
Available Clinical Data and Approved First-line Treatments for ROS1-Altered Advanced NSCLC 13:46

1M ago13:46

13:46

In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available clinical data in support of frontline treatments for ROS1-altered NSCLC including: Efficacy and safety data for crizotinib, entrectinib, and repotrectinib in patients with ROS1-altered advanced NSCLC Long-term safety observations for cri…

1
Exploring stem cell therapy for Hirschsprung disease 14:01

1M ago14:01

14:01

Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Dr Conor McCann from the Department of Stem Cells and Regenerative Medicine, UCL Great Ormond Street Institute of Child Health, London, UK and Dr Anestis Tsakiridis from the School of Biosciences,…

1
Cognition in Psychiatry and Schizophrenia: All You Need to Know in 15 Minutes 19:39

1M ago19:39

19:39

What is processing speed? Does it matter? Learn why it absolutely does for your patients. Credit available for this activity expires: 8/3/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001439?ecd=bdc_podcast_libsyn_mscpedu

1
Data Highlights in Alzheimer's Disease From the 2024 AAIC Annual Meeting 28:48

1M ago28:48

28:48

What's ready for prime time and what's in the pipeline in Alzheimer’s disease (AD) diagnosis and care? View conference highlights to find out. Credit available for this activity expires: 8/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001535?ecd=bdc_podcast_libsyn_mscpedu…

1
Mastering Multiplex Testing for Diagnosing Pneumonia: From Interpretation to Application 31:49

1M ago31:49

31:49

Delve into the impact of revolutionary multiplex testing for diagnosing pneumonia. Credit available for this activity expires: 8/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001528?ecd=bdc_podcast_libsyn_mscpedu

1
Expert Perspectives on the Future of IgA Nephropathy Treatment 30:26

1M ago30:26

30:26

Recent advances in our understanding of immunoglobulin A (IgA) nephropathy (IgAN) have led to an abundance of research into new therapies; our experts will guide you through it all. Credit available for this activity expires: 8/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001534?ecd=bdc_podcast_libsyn…

1
ROS1-Alterations and Molecular Testing in Advanced NSCLC 16:28

1M ago16:28

16:28

In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the current understanding of ROS1 rearrangements in non-small-cell lung cancer tumor biology and its implications for molecular testing and treatment selection including: ROS1-gene fusions in advanced lung cancer ROS1 testing recommendations with DNA …

1
Breaking Down the Burden of IgA Nephropathy With Clinician and Patient Perspectives 18:01

1M ago18:01

18:01

Are your patients' kidneys fighting a silent battle? Our experts give insight on earlier detection of IgAN and react to a real patient's experience. Credit available for this activity expires: 8/23/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001513?ecd=bdc_podcast_libsyn_mscpedu…

1
Putting Data Into Context for Congenital Adrenal Hyperplasia Treatment Advances 26:39

1M ago26:39

26:39

Do you have the latest data on novel therapies for congenital adrenal hyperplasia (CAH)? An expert panel discusses. Credit available for this activity expires: 8/23/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001510?ecd=bdc_podcast_libsyn_mscpedu

1
Myeloma Matters: Bispecific Antibody Horizons: Dosing Strategies and Meeting Updates in Myeloma Care

2M ago

—

Host: Saad Z. Usmani, MD, MBA, FACP Guest: Joshua Richter, MD Guest: Ashley Steinberger, APP Release date: 8/15/2024 Expiration date: 8/15/2025 Estimated time to complete: 1.0 hour This activity is not accredited for CME/CE credit. This episode of Myeloma Matters reviews the latest data on bispecific antibody therapy for relapsed/refractory multipl…

1
Don't Go With Your Gut: Optimizing GI Infection Management With Rapid Diagnostic Panels 32:03

2M ago32:03

32:03

How much do you know about rapid molecular diagnostics for gastrointestinal (GI) infections? Credit available for this activity expires: 08/13/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001464?ecd=bdc_podcast_libsyn_mscpedu

1
The Promise of MCED Testing: Easing the Burden of Cancer Screening Anxiety

2M ago

—

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Christopher Chambers, MD Guest: Adam H. Buchanan, MS, MPH Since multi-cancer early detection (MCED) testing is a new technology, there’s been some discussion in the field about the impact it may have on patients, especially in terms of potential psychological harm like anxiety related to positive test…

1
Midyear Highlights of Key Data From 2024 Gynecologic Cancer Conferences Informing Treatment of Ovarian, Endometrial, and Cervical Cancers 49:32

2M ago49:32

49:32

In this episode, listen to Floor J. Backes, MD, and Angeles Alvarez Secord, MD, MHSc, share their clinical insights and takeaways on new data presented for endometrial, ovarian, and cervical cancers presented at the 2024 annual meetings of the Society of Gynecologic Oncology and American Society of Clinical Oncology including: RUBY Part 1 Subgroup …

1
Protective function of sclerosing cholangitis on IBD 8:20

2M ago8:20

8:20

Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Samuel Huber, from the Department of Medicine, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany, on the paper "Protective function of sclerosing cholangitis on IBD" publish…

1
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques

2M ago

—

Host: Jody Takemoto, PhD Guest: David Braun Identifying biomarkers for renal cell carcinoma (RCC) is critical since they can help direct our therapeutic approach, which is why several techniques that may be able to uncover new biomarkers are currently being investigated. Joining Dr. Jody Takemoto to review those techniques and their potential impac…

1
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes

2M ago

—

Host: Jody Takemoto, PhD Guest: David Braun, MD, PhD A recent study investigated whether renal cell carcinoma (RCC) molecular subtypes have any impact on treatment outcomes. Here to share the surprising findings and their implications is Dr. David Braun, Assistant Professor of Medicine and a member of the Center of Molecular and Cellular Oncology a…

1
The Multiple Layers of Major Depressive Disorder Management: Unravelling the Who, When, and How for Antidepressant Modification 48:51

2M ago48:51

48:51

What do you do when your patients are unravelling due to their antidepressant? Credit available for this activity expires: 7/26/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001393?ecd=bdc_podcast_libsyn_mscpedu

Подкасты, которые стоит послушать

Подкасты на тему Hepatocellular

Подкасты, которые стоит послушать

Краткое руководство